{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T23:32:56Z","timestamp":1777419176983,"version":"3.51.4"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,10,18]],"date-time":"2020-10-18T00:00:00Z","timestamp":1602979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2020,10,18]],"date-time":"2020-10-18T00:00:00Z","timestamp":1602979200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100007514","name":"Universit\u00e0 di Pisa","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007514","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Azienda Ospedaliera Sant\u2019Andrea"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s00280-020-04172-3","type":"journal-article","created":{"date-parts":[[2020,10,18]],"date-time":"2020-10-18T10:02:35Z","timestamp":1603015355000},"page":"841-846","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["All-oral metronomic DEVEC schedule in elderly patients with peripheral T cell lymphoma"],"prefix":"10.1007","volume":"86","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8597-8459","authenticated-orcid":false,"given":"Maria Christina","family":"Cox","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Banchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabrina","family":"Pelliccia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arianna","family":"Di Napoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Marcheselli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caterina","family":"Patti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Anticoli Borza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta","family":"Battistini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Di Gregorio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Orlandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7120-9141","authenticated-orcid":false,"given":"Guido","family":"Bocci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,10,18]]},"reference":[{"key":"4172_CR1","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3322\/caac.21589","volume":"70","author":"E Marchi","year":"2020","unstructured":"Marchi E, O\u2019Connor OA (2020) The rapidly changing landscape in mature T-cell lymphoma (MTCL) biology and management. CA Cancer J Clin 70:47\u201370","journal-title":"CA Cancer J Clin"},{"key":"4172_CR2","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1111\/bjh.15258","volume":"181","author":"M Federico","year":"2018","unstructured":"Federico M, Bellei M, Marcheselli L, Schwartz M, Manni M, Tarantino V et al (2018) Peripheral T cell lymphoma, not otherwise specified (PTCL-NOS). A new prognostic model developed by the International T cell Project Network. Br J Haematol. 181:760\u2013769","journal-title":"Br J Haematol."},{"key":"4172_CR3","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1200\/JCO.2012.44.7524","volume":"31","author":"V Mak","year":"2013","unstructured":"Mak V, Hamm J, Chhanabhai M, Shenkier T, Klasa R, Sehn LH et al (2013) Survival of patients with peripheral T-cell lymphoma after first relapse or progression: spectrum of disease and rare long-term survivors. J Clin Oncol 31:1970\u20131976","journal-title":"J Clin Oncol"},{"key":"4172_CR4","doi-asserted-by":"publisher","first-page":"4688","DOI":"10.1002\/cam4.2364","volume":"8","author":"K Wu","year":"2019","unstructured":"Wu K, Sun XQ, Wang CQ, Gao TX, Sun P, Wang Y et al (2019) Metronomic combination chemotherapy using everolimus and etoposide for the treatment of non-Hodgkin lymphoma. Cancer Med 8:4688\u20134698","journal-title":"Cancer Med"},{"key":"4172_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-018-4885-5","volume":"18","author":"RC Schelker","year":"2018","unstructured":"Schelker RC, Herr W, Reichle A, Vogelhuber M (2018) Low-dose trofosfamide plus rituximab is an effective and safe treatment for diffuse large B-cell lymphoma of the elderly: a single center experience. BMC Cancer 18:1\u20138","journal-title":"BMC Cancer"},{"key":"4172_CR6","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/nrclinonc.2016.64","volume":"13","author":"G Bocci","year":"2016","unstructured":"Bocci G, Kerbel RS (2016) Pharmacokinetics of metronomic chemotherapy: a neglected but crucial aspect. Nat Rev Clin Oncol 13:659\u2013673","journal-title":"Nat Rev Clin Oncol"},{"key":"4172_CR7","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.canlet.2018.06.002","volume":"432","author":"G Natale","year":"2018","unstructured":"Natale G, Bocci G (2018) Does metronomic chemotherapy induce tumor angiogenic dormancy? A review of available preclinical and clinical data. Cancer Lett 432:28\u201337","journal-title":"Cancer Lett"},{"key":"4172_CR8","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.bcp.2018.04.011","volume":"152","author":"P Orlandi","year":"2018","unstructured":"Orlandi P, Di Desidero T, Salvia G, Muscatello B, Francia G, Bocci G (2018) Metronomic vinorelbine is directly active on non small cell lung cancer cells and sensitizes the EGFRL858R\/T790M cells to reversible EGFR tyrosine kinase inhibitors. Biochem Pharmacol 152:327\u2013337","journal-title":"Biochem Pharmacol"},{"key":"4172_CR9","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1007\/s10637-019-00769-5","volume":"37","author":"MC Cox","year":"2019","unstructured":"Cox MC, Pelliccia S, Marcheselli L, Battistini R, Arcari A, Borza PA et al (2019) The metronomic all-oral DEVEC is an effective schedule in elderly patients with diffuse large b-cell lymphoma. Invest New Drugs 37:548\u2013558","journal-title":"Invest New Drugs"},{"key":"4172_CR10","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3109\/10428194.2013.788176","volume":"55","author":"F Merli","year":"2014","unstructured":"Merli F, Luminari S, Rossi G, Mammi C, Marcheselli L, Ferrari A et al (2014) Outcome of frail elderly patients with diffuse large B-cell lymphoma prospectively identified by comprehensive geriatric assessment: results from a study of the fondazione italiana linfomi. Leuk Lymphoma 55:38\u201343","journal-title":"Leuk Lymphoma"},{"key":"4172_CR11","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","volume":"32","author":"BD Cheson","year":"2014","unstructured":"Cheson BD, Fisher RI, Barrington SF, Cavalli F, Schwartz LH, Zucca E et al (2014) Recommendations for initial evaluation, staging, and response assessment of hodgkin and non-hodgkin lymphoma: the lugano classification. J Clin Oncol 32:3059\u20133067","journal-title":"J Clin Oncol"},{"key":"4172_CR12","first-page":"6938","volume":"62","author":"G Bocci","year":"2002","unstructured":"Bocci G, Nicolaou KC, Kerbel RS (2002) Protracted low-dose effects on human endothelial cell proliferation and survival in vitro reveal a selective antiangiogenic window for various chemotherapeutic drugs. Cancer Res 62:6938\u20136943","journal-title":"Cancer Res"},{"key":"4172_CR13","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1002\/cncr.30416","volume":"123","author":"KR Carson","year":"2017","unstructured":"Carson KR, Horwitz SM, Pinter-Brown LC, Rosen ST, Pro B, Hsi ED et al (2017) A prospective cohort study of patients with peripheral T-cell lymphoma in the United States. Cancer 123:1174\u20131183","journal-title":"Cancer"},{"key":"4172_CR14","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/j.1365-2141.2010.08367.x","volume":"152","author":"A Tucci","year":"2011","unstructured":"Tucci A, Cerqui E, Ungari M, Ferrari S, Baushi L, Facchetti F et al (2011) Continuous oral cyclophosphamide and prednisolone as a valuable treatment option for peripheral T cell lymphoma. Br J Haematol 152:113\u2013116","journal-title":"Br J Haematol"},{"key":"4172_CR15","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.3109\/10428194.2015.1055484","volume":"57","author":"S Yuan","year":"2016","unstructured":"Yuan S, Yu J, Haverkos B, Su H (2016) Remission of an extensively pre-treated relapsing\/refractory ALK-positive anaplastic large cell lymphoma following metronomic therapy. Leuk Lymphoma 57:1194\u20131196","journal-title":"Leuk Lymphoma"},{"key":"4172_CR16","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1002\/cncr.23422","volume":"112","author":"M Coleman","year":"2008","unstructured":"Coleman M, Martin P, Ruan J, Furman R, Niesvizky R, Elstrom R et al (2008) Prednisone, etoposide, procarbazine, and cyclophosphamide (PEP-C) oral combination chemotherapy regimen for recurring\/refractory lymphoma: Low-dose metronomic, multidrug therapy. Cancer 112:2228\u20132232","journal-title":"Cancer"},{"issue":"6","key":"4172_CR17","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1007\/s10637-016-0385-0","volume":"34","author":"T Di Desidero","year":"2016","unstructured":"Di Desidero T, Derosa L, Galli L, Orlandi P, Fontana A, Fioravanti A et al (2016) Clinical, pharmacodynamic and pharmacokinetic results of a prospective phase II study on oral metronomic vinorelbine and dexamethasone in castration-resistant prostate cancer patients. Invest New Drugs 34(6):760\u2013770","journal-title":"Invest New Drugs"},{"key":"4172_CR18","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s00280-007-0428-5","volume":"60","author":"W Peng Yong","year":"2007","unstructured":"Peng Yong W, Desai AA, Innocenti F, Ramirez J, Shepard D, Kobayashi K et al (2007) Pharmacokinetic modulation of oral etoposide by ketoconazole in patients with advanced cancer. Cancer Chemother Pharmacol 60:811\u2013819","journal-title":"Cancer Chemother Pharmacol"},{"key":"4172_CR19","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jgo.2019.03.016","volume":"11","author":"K Wudhikarn","year":"2020","unstructured":"Wudhikarn K, Bunworasate U, Julamanee J, Lekhakula A, Ekwattanakit S, Khuhapinant A et al (2020) Characteristics, treatment patterns, prognostic determinants and outcome of peripheral T cell lymphoma and natural killer\/T cell non-Hodgkin lymphoma in older patients: the result of the nationwide multi-institutional registry Thai lymphoma study group. J Geriatr Oncol 11:62\u201368","journal-title":"J Geriatr Oncol"},{"issue":"8","key":"4172_CR20","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1002\/ajh.25513","volume":"94","author":"JM Zain","year":"2019","unstructured":"Zain JM (2019) Aggressive T-cell lymphomas: 2019 updates on diagnosis, risk stratification, and management. Am J Hematol 94(8):929\u2013946","journal-title":"Am J Hematol"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-020-04172-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00280-020-04172-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-020-04172-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T06:16:08Z","timestamp":1744179368000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00280-020-04172-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,18]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["4172"],"URL":"https:\/\/doi.org\/10.1007\/s00280-020-04172-3","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,18]]},"assertion":[{"value":"4 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no conflict of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"It was waived by the local Ethics Committee of Sapienza University in view of the retrospective nature of the study and all the procedures being performed were part of the routine care.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Patients signed informed consent regarding publishing their data.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}]}}